PROTECTING YOUR RIGHT TO MEDICINES AND MEDICAL DEVICES
Sunday, 01 August 2021

Activities of the Pharmacovigilance & Clinical Trials are:

*To approve and monitor all clinical trials medicines and medical devices that are conducted in Zimbabwe in terms of Part III of the Medicines and Allied Substances Control Act of 1991 [Chapter 15:03]. 

*To deal with medicine's post-registration issues. This means that after medicines have been registered by the Authority, any issues to do with the review of those medicines fall under this unit, including the processing of applications for amendments for registered medicines.

*To approve and monitor all clinical trials involving medicines and medical devices that are conducted in Zimbabwe in terms of Part III of the Medicines and Allied Substances Control Act of 1991 [Chapter 15:03]

*To conduct Pharmacovigilance activities which include: post-market surveillance of registered medicines; collecting and analysing Adverse Drug reports;

*Drug information dissemination through publishing a quarterly drug information bulletin.

 

Latest News

Quality Policy Statement

20 April 2021
Quality Policy Statement

The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient...

Covid-19 Vaccine Applications Submission Guidance

12 January 2021
Covid-19 Vaccine Applications Submission Guidance

Guidance on submission of covid-19 vaccine applications for emergency use authorisation and registration have been published. Click  MCAZ COVID-19 VACCINE GUIDANCE-VERSION 11 download the guideline.

2019 Customer Complaints Trends Analysis

29 October 2020
2019 Customer Complaints Trends Analysis

  In order to improve service delivery to our valued customers, MCAZ collects information on Customer Complaints.   To download the 2019 Customer Complaints Trends Analysis Click here 

MCAZ Covid-19 Health and Safety Guidelines

29 September 2020
MCAZ Covid-19 Health and Safety Guidelines

The Medicines Control Authority of Zimbabwe (MCAZ) Covid-19 Health and Safety Guidelines applies to MCAZ staff with the intention of preventing workplace infections, protecting lives, and promoting employee health for...

Draft Medicines and Allied Substances Control (Blood and Blood Components) Regulations

26 June 2020
Draft Medicines and Allied Substances Control (Blood and Blood Components) Regulations

 The draft Blood and Blood Components Regulations are now available Please note that this is a DRAFT  that has been uploaded to obtain comments from stakeholders before the regulations are...

Medical Product Alert ; Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

06 April 2020
Medical Product Alert ; Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

  This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat orcure COVID-19.   Medical...

Draft SADC Variations Guidelines

20 March 2020

Draft SADC Variations Guidelines are now available  Click the following links to download the guidelines and the comments sheet Draft SADC Variations Guidelines Draft SADC Variations Guidelines Comments Sheet

Code of Ethics

22 August 2019
Code of Ethics

  In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical...

SADC Guideline on Product Information and Labeling

10 July 2019
SADC Guideline on Product Information and Labeling

  Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...

Feedback Forms